Loading...
Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000–2008
BACKGROUND: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in hemophilia patients with inhibitors but has been applied to a wide range of off-label indications. OBJECTIVE: To estimate patterns of off-label rFVIIa use in United States hospitals. DESIGN: Retrospective database...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4011398/ https://ncbi.nlm.nih.gov/pubmed/21502649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/0003-4819-154-8-201104190-00002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|